The efficacy of femoral nerve block in pain reduction for outpatient hamstring anterior cruciate ligament reconstruction: A double-blind, prospective, randomized trial
S. Frost et al., The efficacy of femoral nerve block in pain reduction for outpatient hamstring anterior cruciate ligament reconstruction: A double-blind, prospective, randomized trial, ARTHROSCOPY, 16(3), 2000, pp. 243-248
The purpose of this study was to assess the efficacy of intraoperative femo
ral nerve block (FNB) in the reduction of postoperative pain following ante
rior cruciate ligament (ACL) hamstring reconstruction. Patients undergoing
primary ACL reconstruction with hamstring tendon graft under general anesth
etic who had signed an informed consent were included in the study. Patient
s were stratified to 4 surgeons and randomized to FNB with 0.25% bupivacain
e or placebo of normal saline injected into the femoral nerve sheath before
reversal of the general anesthetic. All patients received an intra-articul
ar injection of bupivacaine at the beginning of their operative procedure.
A single technique that included the use of a peripheral nerve stimulator w
as used for all FNBs. All patients were discharged on the day of surgery an
d given prescriptions for Tylenol 3. The Short-Form McGill Pain Questionnai
re (SF-MPQ), a visual analog scale (VAS) for pain, and a medication diary r
ecording Tylenol 3 usage were completed by patients in the recovery room, o
n the night of surgery, and on postoperative days 1, 2, and 3. There were c
omplete data for 61 patients (FNB, 29; placebo, 32). An analysis of varianc
e (ANOVA) test of the data showed no significant difference between the FNB
and placebo group for pain reduction over the combined study period for bo
th the SF-MPQ and VAS. However, the ANOVA does suggest that, on the night o
f surgery, there was a significant reduction in pain as measured with the V
AS in the FNB group. A Student t test performed on the night of surgery dat
a (SF-MPQ, P = .131; VAS, P = .0114; Tylenol 3, P = .076) showed a statisti
cally significant difference between the FNB (39.4 +/- 21.0 mm) and placebo
(56.8.0 +/- 24.6 mm) measured by VAS. Because this represented a differenc
e of only 1.74 cm on a 10-cm VAS, it is unlikely to be clinically relevant.
No difference was found in the amount of analgesic required on any day pos
toperatively. In conclusion, FNB may reduce pain on the night of surgery. H
owever, this may not be clinically significant. FNB is not recommended at t
his time for use in outpatient ACL reconstruction with hamstring graft.